Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

VAISHALI PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 2.11-68.1133.8294.6045.00

What is the latest Core EBITDA Growth ratio of VAISHALI PHARMA ?

The latest Core EBITDA Growth ratio of VAISHALI PHARMA is 2.11 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar20252.11
Mar2024-68.11
Mar202333.82
Mar202294.60
Mar202145.00

How is Core EBITDA Growth of VAISHALI PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 2.11
Positive
Mar2024 -68.11
Negative
Mar2023 33.82
-64.25
Mar2022 94.6
110.22
Mar2021 45 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹84.7 Cr 9.1% -0.3% -50.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

9.1%

-0.3%

-50.3%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses